Are ketogenic diets promising for Alzheimer's disease? A translational review

被引:47
|
作者
Lilamand, Matthieu [1 ,2 ,3 ,4 ]
Porte, Baptiste [1 ,2 ]
Cognat, Emmanuel [1 ,2 ]
Hugon, Jacques [1 ,2 ]
Mouton-Liger, Francois [1 ,2 ]
Paquet, Claire [1 ,2 ]
机构
[1] Univ Paris, INSERM, U1144, Optimisat Therapeut Neuropsychopharmacol, Paris, France
[2] Nord Univ Paris, Lariboisiere Hosp, APHP, CMRR Paris Nord Ile France,Ctr Neurol Cognit, 200 Rue Faubourg, F-75010 Paris, France
[3] APHP Nord Univ Paris, Dept Geriatr, Bichat, Bretonneau Hospitals, F-75018 Paris, France
[4] Nord Univ Paris, Bichat & Bretonneau Hosp, APHP, Dept Geriatr, F-75018 Paris, France
关键词
Ketogenic diet; Alzheimer's disease; Brain metabolism; Animal models; MOUSE MODEL; COGNITIVE IMPAIRMENT; BETA-HYDROXYBUTYRATE; KETONE ESTER; SUPPLEMENTATION; METABOLISM; MITOCHONDRIA; MEMORY;
D O I
10.1186/s13195-020-00615-4
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background Brain amyloid deposition and neurofibrillary tangles in Alzheimer's disease (AD) are associated with complex neuroinflammatory reactions such as microglial activation and cytokine production. Glucose metabolism is closely related to neuroinflammation. Ketogenic diets (KDs) include a high amount of fat, low carbohydrate and medium-chain triglyceride (MCT) intake. KDs lead to the production of ketone bodies to fuel the brain, in the absence of glucose. These nutritional interventions are validated treatments of pharmacoresistant epilepsy, consequently leading to a better intellectual development in epileptic children. In neurodegenerative diseases and cognitive decline, potential benefits of KD were previously pointed out, but the published evidence remains scarce. The main objective of this review was to critically examine the evidence regarding KD or MCT intake effects both in AD and ageing animal models and in humans. Main body We conducted a review based on a systematic search of interventional trials published from January 2000 to March 2019 found on MEDLINE and Cochrane databases. Overall, 11 animal and 11 human studies were included in the present review. In preclinical studies, this review revealed an improvement of cognition and motor function in AD mouse model and ageing animals. However, the KD and ketone supplementation were also associated with significant weight loss. In human studies, most of the published articles showed a significant improvement of cognitive outcomes (global cognition, memory and executive functions) with ketone supplementation or KD, regardless of the severity of cognitive impairments previously detected. Both interventions seemed acceptable and efficient to achieve ketosis. Conclusion The KD or MCT intake might be promising ways to alter cognitive symptoms in AD, especially at the prodromal stage of the disease. The need for efficient disease-modifying strategies suggests to pursue further KD interventional studies to assess the efficacy, the adherence to this diet and the potential adverse effects of these nutritional approaches.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Promising agents for treating Alzheimer's disease
    Simonson, W
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1998, 55 : S11 - S16
  • [32] Translational research in Alzheimer's disease and Parkinson's disease.
    Schmechel, Don
    NEUROTOXICOLOGY, 2006, 27 (06) : 1157 - 1157
  • [33] A promising new treatment for Alzheimer's disease?
    O'Brien, John T.
    LANCET NEUROLOGY, 2008, 7 (09): : 768 - 769
  • [34] Translational Research in Genomics of Alzheimer's Disease: A Review of Current Practice and Future Perspectives
    Mihaescu, Raluca
    Detmar, Symone B.
    Cornel, Martina C.
    van der Flier, Wiesje M.
    Heutink, Peter
    Hol, Elly M.
    Rikkert, Marcel G. M. Olde
    van Duijn, Cornelia M.
    Janssens, A. Cecile J. W.
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 20 (04) : 967 - 980
  • [35] Promising developments in neuropsychological approaches for the detection of preclinical Alzheimer's disease: a selective review
    Rentz, Dorene M.
    Rodriguez, Mario A. Parra
    Amariglio, Rebecca
    Stern, Yaakov
    Sperling, Reisa
    Ferris, Steven
    ALZHEIMERS RESEARCH & THERAPY, 2013, 5 (06):
  • [36] Promising developments in neuropsychological approaches for the detection of preclinical Alzheimer’s disease: a selective review
    Dorene M Rentz
    Mario A Parra Rodriguez
    Rebecca Amariglio
    Yaakov Stern
    Reisa Sperling
    Steven Ferris
    Alzheimer's Research & Therapy, 5
  • [37] Ketogenic diets: An historical antiepileptic therapy with promising potentialities for the aging brain
    Balietti, Marta
    Casoli, Tiziana
    Di Stefano, Giuseppina
    Giorgetti, Belinda
    Aicardi, Giorgio
    Fattoretti, Patrizia
    AGEING RESEARCH REVIEWS, 2010, 9 (03) : 273 - 279
  • [38] A review of low-carbohydrate ketogenic diets
    Eric C. Westman
    John Mavropoulos
    William S. Yancy
    Jeff S. Volek
    Current Atherosclerosis Reports, 2003, 5 (6) : 476 - 483
  • [39] Ketogenic Diet: A Promising Neuroprotective Composition for Managing Alzheimer's Diseases and its Pathological Mechanisms
    Sridharan, Badrinathan
    Lee, Meng-Jen
    CURRENT MOLECULAR MEDICINE, 2022, 22 (07) : 640 - 656
  • [40] Translational profiling of microglia in Alzheimer's disease models
    Fryer, John D.
    Kang, Silvia S.
    JOURNAL OF IMMUNOLOGY, 2018, 200 (01):